Pharma Foods International Balance Sheet Health
Financial Health criteria checks 5/6
Pharma Foods International has a total shareholder equity of ¥11.6B and total debt of ¥16.9B, which brings its debt-to-equity ratio to 145.8%. Its total assets and total liabilities are ¥36.6B and ¥25.0B respectively. Pharma Foods International's EBIT is ¥5.1B making its interest coverage ratio 155. It has cash and short-term investments of ¥15.7B.
Key information
145.8%
Debt to equity ratio
JP¥16.89b
Debt
Interest coverage ratio | 155x |
Cash | JP¥15.67b |
Equity | JP¥11.59b |
Total liabilities | JP¥24.99b |
Total assets | JP¥36.57b |
Recent financial health updates
Recent updates
Pharma Foods International Co., Ltd.'s (TSE:2929) Prospects Need A Boost To Lift Shares
Oct 31We Think Pharma Foods International's (TSE:2929) Solid Earnings Are Understated
Sep 22Is Pharma Foods International (TSE:2929) Using Too Much Debt?
Jul 23We Like Pharma Foods International's (TSE:2929) Earnings For More Than Just Statutory Profit
Mar 23Financial Position Analysis
Short Term Liabilities: 2929's short term assets (¥27.3B) exceed its short term liabilities (¥23.2B).
Long Term Liabilities: 2929's short term assets (¥27.3B) exceed its long term liabilities (¥1.8B).
Debt to Equity History and Analysis
Debt Level: 2929's net debt to equity ratio (10.6%) is considered satisfactory.
Reducing Debt: 2929's debt to equity ratio has increased from 72% to 145.8% over the past 5 years.
Debt Coverage: 2929's debt is well covered by operating cash flow (32.5%).
Interest Coverage: 2929's interest payments on its debt are well covered by EBIT (155x coverage).